These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 3981499

  • 1. Plasma and synovial fluid gentisate in patients receiving salicylate therapy.
    Cleland LG, Lowthian PJ, Imhoff D, Bochner F, Betts WH, O'Callaghan J.
    J Rheumatol; 1985 Feb; 12(1):136-9. PubMed ID: 3981499
    [Abstract] [Full Text] [Related]

  • 2. Gentisate, a salicylate metabolite with antioxidant properties.
    Cleland LG, Whitehouse MW, Betts WH.
    Drugs Exp Clin Res; 1985 Feb; 11(8):463-7. PubMed ID: 3879751
    [Abstract] [Full Text] [Related]

  • 3. Plasma and synovial fluid concentrations of salicylic acid and its metabolites in patients with joint effusions.
    Sitar DS, Chalmers IM, Hunter T.
    J Rheumatol; 1985 Feb; 12(1):134-5. PubMed ID: 3981498
    [Abstract] [Full Text] [Related]

  • 4. [The distribution of benorylate in plasma, synovial fluid and synovial tissue in rheumatoid arthritis].
    Manz G, Glynn JP.
    Z Rheumatol; 1975 Feb; 34(11-12):400-7. PubMed ID: 1915
    [Abstract] [Full Text] [Related]

  • 5. Simultaneous pharmacokinetics of benorylate in plasma and synovial fluid of patients with rheumatoid arthritis.
    Aylward M, Maddock J, Rees P, Thomas GM, Wheeldon R, Holly F.
    Scand J Rheumatol Suppl; 1975 Feb; 13():9-12. PubMed ID: 8841
    [Abstract] [Full Text] [Related]

  • 6. Functional analysis of rheumatoid factor-producing B cells from the synovial fluid of rheumatoid arthritis patients.
    Reparon-Schuijt CC, van Esch WJ, van Kooten C, Levarht EW, Breedveld FC, Verweij CL.
    Arthritis Rheum; 1998 Dec; 41(12):2211-20. PubMed ID: 9870878
    [Abstract] [Full Text] [Related]

  • 7. Transsynovial kinetics of lonazolac and its hydroxy metabolite in synovitis patients.
    Deneke J, Luckow V, Guserle R, Pässler HH.
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):418-24. PubMed ID: 9726694
    [Abstract] [Full Text] [Related]

  • 8. Differences in sodium salicylate protein binding in serum and synovial fluid from patients with a knee effusion.
    Caillier I, Bannwarth B, Monot C, Lapicque F, Netter P, Gaucher A, Royer RJ.
    Int J Clin Pharmacol Ther Toxicol; 1990 Jan; 28(1):7-13. PubMed ID: 2303312
    [Abstract] [Full Text] [Related]

  • 9. Reactive oxygen species and hyaluronate in serum and synovial fluid in arthritis.
    Saari H, Sorsa T, Konttinen YT.
    Int J Tissue React; 1990 Jan; 12(2):81-9. PubMed ID: 2210971
    [Abstract] [Full Text] [Related]

  • 10. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control.
    Pullerits R, Bokarewa M, Dahlberg L, Tarkowski A.
    Arthritis Res Ther; 2005 Jan; 7(4):R817-24. PubMed ID: 15987483
    [Abstract] [Full Text] [Related]

  • 11. Concentrations of tolmetin in plasma and synovial fluid after a single intake in patients with rheumatoid arthritis.
    Franchimont P, Hauwaert C, Mailleux E.
    Eur J Rheumatol Inflamm; 1981 Jan; 4(3):387-91. PubMed ID: 6242961
    [No Abstract] [Full Text] [Related]

  • 12. Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis.
    Maurice MM, Nakamura H, Gringhuis S, Okamoto T, Yoshida S, Kullmann F, Lechner S, van der Voort EA, Leow A, Versendaal J, Muller-Ladner U, Yodoi J, Tak PP, Breedveld FC, Verweij CL.
    Arthritis Rheum; 1999 Nov; 42(11):2430-9. PubMed ID: 10555039
    [Abstract] [Full Text] [Related]

  • 13. Inability to interpret toxic salicylate levels in patients taking aspirin and diflunisal.
    Adelman HM, Wallach PM, Flannery MT.
    J Rheumatol; 1991 Apr; 18(4):522-3. PubMed ID: 2066942
    [Abstract] [Full Text] [Related]

  • 14. [The presence of salicylate and its metabolites in the joint exudates of subjects with chronic arthritis treated with salicylate].
    Arata L, D'Avino R, Iacovoni P, Pecora P.
    Boll Soc Ital Biol Sper; 1970 Jan 30; 46(2):56-8. PubMed ID: 5419766
    [No Abstract] [Full Text] [Related]

  • 15. Dissociation of acetylsalicylic acid in blood and joint fluid.
    Soren A.
    Scand J Rheumatol; 1977 Jan 30; 6(1):17-22. PubMed ID: 850778
    [Abstract] [Full Text] [Related]

  • 16. Characterization of salicylate binding to synovial fluid and plasma protein in patients with rheumatoid arthritis.
    Trnavská Z, Trnavský K.
    Eur J Clin Pharmacol; 1980 Nov 30; 18(5):403-6. PubMed ID: 7439262
    [Abstract] [Full Text] [Related]

  • 17. [Transport of salicylates from blood to joint fluid (author's transl)].
    Soren A.
    Wien Klin Wochenschr; 1977 Sep 16; 89(17):599-602. PubMed ID: 906524
    [Abstract] [Full Text] [Related]

  • 18. [Plasma and synovial fibronectin. Results of personal research].
    Lecocq J, North ML, Grange D, Hauptmann G, Kuntz JL, Meyer R, Asch L.
    Rev Rhum Mal Osteoartic; 1984 Sep 16; 51(7-8):393-8. PubMed ID: 6494778
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
    Khan F, Siddiqui AA.
    Clin Chim Acta; 2006 Aug 16; 370(1-2):100-7. PubMed ID: 16513103
    [Abstract] [Full Text] [Related]

  • 20. Aromatic hydroxylation as a potential measure of hydroxyl-radical formation in vivo. Identification of hydroxylated derivatives of salicylate in human body fluids.
    Grootveld M, Halliwell B.
    Biochem J; 1986 Jul 15; 237(2):499-504. PubMed ID: 3026319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.